Skip to content
healthcare.dev
Get a free key

Guaifenesin

NDC 65162-037, Guaifenesin, tablet, extended release, from Amneal Pharmaceuticals LLC.

Product NDC
65162-037
Status
Listed
Labeler
Amneal Pharmaceuticals LLC
Dosage form
TABLET, EXTENDED RELEASE
Route
ORAL
Product type
HUMAN OTC DRUG
Marketing category
ANDA
Application
ANDA207342
DEA schedule
None
Request
curl https://api.healthcare.dev/v1/drugs/ndc/65162-037 \
  -H "Authorization: Bearer $HDEV_API_KEY"

Product

Active ingredients and packages

Active ingredients

  • GUAIFENESIN1200 mg/1

Pharmacologic classes

Decreased Respiratory Secretion Viscosity [PE]; Expectorant [EPC]; Increased Respiratory Secretions [PE]

Package NDCNDC-11Package
65162-037-03651620037031 BOTTLE in 1 CARTON (65162-037-03) / 30 TABLET, EXTENDED RELEASE in 1 BOTTLE
65162-037-06651620037061 BOTTLE in 1 CARTON (65162-037-06) / 60 TABLET, EXTENDED RELEASE in 1 BOTTLE
65162-037-28651620037282 BLISTER PACK in 1 CARTON (65162-037-28) / 14 TABLET, EXTENDED RELEASE in 1 BLISTER PACK

Linked data

RxNorm, label and prices

RxNorm concepts

Related lookups

No FDA label, Medicare Part B payment limit or NADAC price is linked to this product.

Use it

Look up 65162-037 from code or an agent

curl
curl https://api.healthcare.dev/v1/drugs/ndc/65162-037 \
  -H "Authorization: Bearer $HDEV_API_KEY"
MCP prompt
Using the healthcare.dev MCP server, look up NDC 65162-037. Tell me the product, its labeler, dosage form and route, its packages, and the RxNorm concepts it maps to.
Get a free keyNDC docsConnect the MCP server

Source: FDA, release 2026-10-23. Public domain. Reference data, not medical advice.